Historically, submissions have spiked at pre-election meetings as companies rush to avoid the process delays associated with an election, including the listing pauses during the official caretaker period. Officials have previously managed these spikes by adjusting the process.
This has happened before, there was consultation, and it was managed without harming patients
October 23, 2024 Latest NewsBioPharmaLatest Video
New Stories
-
The health department's strategy is based on the 'hope' that sponsors do not submit and enforce their rights
October 24, 2024 - - Latest News -
Health department attempts to defer two-thirds of submissions to March meeting
October 24, 2024 - - Latest News -
Release of white paper from NZ's Valuing Life Medicines Access Summit
October 24, 2024 - - Latest News -
This has happened before, there was consultation, and it was managed without harming patients
October 23, 2024 - - Latest News -
Companies should reject the letters and proceed with their submissions
October 23, 2024 - - Latest News -
'Our job as advocates is to interpret what patients mean by hope, not to ignore it'
October 23, 2024 - - Latest News -
Daiichi Sankyo continues Australian growth trajectory
October 23, 2024 - - Latest News